0000899243-21-006348.txt : 20210212 0000899243-21-006348.hdr.sgml : 20210212 20210212174201 ACCESSION NUMBER: 0000899243-21-006348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Philina CENTRAL INDEX KEY: 0001845080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39344 FILM NUMBER: 21630172 MAIL ADDRESS: STREET 1: C/O FUSION PHARMACEUTICALS, INC. STREET 2: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: D0 ZIP: L8P OA6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001805890 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 BUSINESS PHONE: 289-799-0891 MAIL ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-11 0 0001805890 Fusion Pharmaceuticals Inc. FUSN 0001845080 Lee Philina C/O FUSION PHARMACEUTICALS INC 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 ONTARIO, CANADA 1 0 0 0 Stock Option (Right to Buy) 11.75 2021-02-11 4 A 0 30000 0.00 A 2031-02-10 Common Shares 30000 30000 D The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on March 11, 2021. /s/ Maria Stahl, Attorney-in-Fact 2021-02-12